Health
Convalescent plasma is still in demand. But there are caveats – ABC News
This is a Kaiser Health News story.
Six months after it was controversially hailed by Trump administration officials as a breakthrough therapy to fight the worst effects of covid-19, convalescent plasma appears to be on the ropes.
The treatment that infuses blood plasma from recovered covid patients into people newly infected in hopes of boosting their immune response has not lived up to early hype. Some high-profile clinical trials have shown disappointing results. Demand from hospitals for the…
-
General19 hours agoVictorian school teacher charged with soliciting child abuse material
-
General11 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News15 hours agoPalestine protesters forced into last-minute reroute
-
Business15 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?